Comparison of radial extracorporeal shockwave therapy with ultrasound therapy in patients with lateral epicondylitis

Dedes, Vasileios; Tzirogiannis, Konstantinos; Polikandrioti, Maria; Dede, Ariadni Maria; Mitseas, Athanasios; Panoutsopoulos, Georgios I.

doi:10.1007/s10396-019-01002-9

Cited by 19 publications

(19 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This evidence reinforces the idea that the pain-control effect of ESWT is likely to be mediated by its effect on pain mediators, and substance P and CGRP more specifically. The clinical benefits of ESWT have been reported for a range of orthopedic disorders and associated with self-reported improvements in function and quality of life [30][31][32].…”

Section: Discussionmentioning

confidence: 99%

Clinical Utility of Extracorporeal Shock Wave Therapy on Hypertrophic Scars of the Hand Caused by Burn Injury: A Prospective, Randomized, Double-Blinded Study

Joo

Lee

Cho

et al. 2020

JCM

View full text Add to dashboard Cite

Postburn hypertrophic scarring is a common complication in burn injuries to the hands, often associated with impaired hand function. We evaluated the effects of extracorporeal shock wave therapy (ESWT), compared to a sham stimulation therapy, on hypertrophic scars of the hand caused by burn injury and investigated its effects on hand function. This was a double-blinded, randomized, controlled trial of 48 patients with a burn to their dominant right hand. The parameters of ESWT were as follows: energy flux density, 0.05–0.30 mJ/mm2; frequency, 4 Hz; 1000 to 2000 impulses per treatment; four treatments, once a week for four weeks. The outcomes measured were as follows: a 10-point visual analogue scale pain score; Vancouver scar scale for scar vascularity, height, pliability and pigmentation; ultrasound measurement of scar thickness; Jebsen−Taylor hand function test; grip strength; Perdue pegboard test; and the Michigan hand outcomes questionnaire. The change in the score from baseline to post-treatment was compared between the two groups. ESWT improved the pain score (p = 0.001), scar thickness (p = 0.018), scar vascularity (p = 0.0015), and improved hand function (simulated card-turning, p = 0.02; picking up small objects, p = 0.004). The other measured outcomes were not different between the two groups. ESWT is effective in decreasing pain, suppressing hypertrophic scarring, and improving hand function.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Utility of Extracorporeal Shock Wave Therapy on Hypertrophic Scars of the Hand Caused by Burn Injury: A Prospective, Randomized, Double-Blinded Study

Joo

Lee

Cho

et al. 2020

JCM

View full text Add to dashboard Cite

show abstract

“…Some reviews have maintained that ESWT had beneficial effects on CMPC, such as chronic pelvic pain, neck pain, tennis elbow, and plantar fasciitis. [ 17 – 20 ] Meanwhile, some experimental data in the effect of ESWT treating chronic pain conditions are somewhat controversial. [ 21 – 23 ] Furthermore, most reviews focused on only 1 disorder or were just qualitative analysis, and majority of these reviews did not include Chinese trials of ESWT for CMPC.…”

Section: Discussionmentioning

confidence: 99%

The efficacy of extracorporeal shock wave for chronic musculoskeletal pain conditions

Qin

Jin

et al. 2020

Medicine

View full text Add to dashboard Cite

Background: This systematic review is the first one to assess the effectiveness and safety of extracorporeal shock-wave therapy (ESWT) for patients with chronic musculoskeletal pain conditions (CMPC). Methods: Seven electronic databases were searched for all relevant literature from inception to December 2019, including PubMed, the Web of Science, EMBASE, Cochrane library, China National Knowledge Infrastructure Database (CNKI), Chinese Scientific Journal Database (VIP), and Wanfang database. Only randomized controlled trials (RCTs) of ESWT for chronic musculoskeletal pain will be included. Two reviewers will independently select eligible studies and collected the detailed information, assessed the methodological quality. A third reviewer will join in discussion to solve disagreements. The mean difference (MD) or standard mean difference (SMD) with 95% confidence intervals (CIs) will be presented to demonstrate the effectiveness of ESWT for patients with chronic MSK pain conditions. RevMan 5.4 software will be used for statistical analysis. Results: This systematic review will explore the effectiveness and safety of ESWT for patients with CMPC. The primary outcome includes pain level, and secondary outcome includes function limitation and adverse events. Conclusion: It can provide the updated evidence which is of great importance for patients, clinical practice and health related policy maker in ESWT treating CMPC.

show abstract

“…Some studies have reported the efficacy of US in LET treatment, but with low grade of study design and data, 40 and most of them focused on the comparison between US and ESWT. [41][42][43][44][45] Both Yalvaç B 43 and Özmen T 41 have shown significant improvements in pain, upper limb function, strength and quality of life from baseline after treatment with US. However, they did not have a control group, which would make it unclear whether the efficacy comes from US itself or the passing time, as LET is a self-limiting disease.…”

Section: Strengths and Limitations Of This Studymentioning

confidence: 99%

Efficacy of ultrasound therapy for the treatment of lateral elbow tendinopathy (the UCICLET Trial): study protocol for a three-arm, prospective, multicentre, randomised controlled trial

et al. 2022

View full text Add to dashboard Cite

IntroductionLateral elbow tendinopathy (LET) is a highly prevalent disease among the middle-aged population, with no consensus on optimal management. Non-operative treatment is generally accepted as the first-line intervention. Ultrasound (US) therapy has been reported to be beneficial for various orthopaedic diseases, including tendinopathy. The purpose of this study is to investigate the efficacy of US for LET treatment.Methods and analysisThis protocol entails a three-arm, prospective, multicentre, randomised controlled trial. Seventy-two eligible participants with clinically confirmed LET will be assigned to either (1) US, (2) corticosteroid injections or (3) control group. All participants will receive exercise-based therapy as a fundamental intervention. The primary outcome is Patient-rated Tennis Elbow Evaluation. The secondary outcomes include Visual Analogue Scale for pain, shortened version of the Disabilities of the Arm, Shoulder and Hand for upper limb disability, pain free/maximum grip strength, Work Limitations Questionnaire-25 for functional limitations at work, EuroQol-5D for general health, Hospital Anxiety and Depression Scale for mental status, Global Rating of Change for treatment success and recurrence rate, and Mahomed Scale for the participant’s satisfaction. Adverse events will be recorded. Intention-to-treat analyses will be used.Ethics and disseminationEthics committees of all clinical centres have approved this study. The leading centre is Shanghai Sixth People’s Hospital, whose approval number is 2021–153. New versions with appropriate amendments will be submitted to the committee for further approval. Final results will be published in peer-reviewed journals and presented at local, national and international conferences.Trial registration numberChiCTR2100050547.

show abstract

Comparison of radial extracorporeal shockwave therapy with ultrasound therapy in patients with lateral epicondylitis

Cited by 19 publications

References 23 publications

Clinical Utility of Extracorporeal Shock Wave Therapy on Hypertrophic Scars of the Hand Caused by Burn Injury: A Prospective, Randomized, Double-Blinded Study

Clinical Utility of Extracorporeal Shock Wave Therapy on Hypertrophic Scars of the Hand Caused by Burn Injury: A Prospective, Randomized, Double-Blinded Study

The efficacy of extracorporeal shock wave for chronic musculoskeletal pain conditions

Efficacy of ultrasound therapy for the treatment of lateral elbow tendinopathy (the UCICLET Trial): study protocol for a three-arm, prospective, multicentre, randomised controlled trial

Contact Info

Product

Resources

About